AspenBio Pharma, Inc.·4

Dec 13, 6:33 PM ET

FAULKNER DARYL 4

4 · AspenBio Pharma, Inc. · Filed Dec 13, 2012

Insider Transaction Report

Form 4
Period: 2012-12-11
FAULKNER DARYL
DirectorCEO and Executive Chairman
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-12-11+45,00445,004 total
    Exercise: $2.10Exp: 2022-12-11Common Stock (45,004 underlying)
Footnotes (1)
  • [F1]The option to purchase 45,004 shares of common stock shall become exercisable in full on December 11, 2013.

Documents

1 file
  • 4
    appy_faulkner.xmlPrimary